Mark Baldry, Chief Commercial Officer at X4 Pharmaceuticals, Inc (XFOR), sold 11,127 shares at $0.58 ($6K) on 2024-10-07, disclosed to the SEC on 2024-10-08.
Scheduled sale ($6k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XFOR | SELL | 2023-11-03 | $7K | — | Filing → |